SantéCorp Holding Ltda. acquisition

Grupo Fleury S.A. ("Fleury" or "Company"), pursuant to paragraph 4 of article 157 of Law 6.404/76 and CVM Instruction 358/02, informs its shareholders and the market in general that, on December 4, 2018, Fleury Centro de Procedimentos Médicos Avançados S.A. ("CPMA"), a Company’s subsidiary, has entered into a Sales and Purchase Agreement ("Agreement"), to acquire 100% of the emission quotas of SantéCorp Holding Ltda. ("SantéCorp").

SantéCorp operates in healthcare management services through consulting and advisory tools in the healthcare coordination segment. This acquisition will allow Grupo Fleury to develop a strategic presence in the healthcare management segment.

The acquisition value is R$15.5 million (fifteen million and five hundred thousand reais) before deductions and adjustments.

This acquisition is not subject to the resolution of the Company‘s shareholders, nor will it give rise to the right of withdrawal, in view of the terms of item 7.3 of Circular Letter CVM/SEP/No. 02/2018.